MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $219,000 | -80.6% | 2,667 | -61.9% | 0.01% | -78.4% |
| Q2 2021 | $1,130,000 | +2656.1% | 6,997 | +2791.3% | 0.04% | +3600.0% |
| Q1 2021 | $41,000 | -39.7% | 242 | -21.7% | 0.00% | -66.7% |
| Q4 2020 | $68,000 | -29.2% | 309 | -63.1% | 0.00% | -72.7% |
| Q2 2020 | $96,000 | +772.7% | 838 | +474.0% | 0.01% | +266.7% |
| Q3 2019 | $11,000 | +450.0% | 146 | +329.4% | 0.00% | +200.0% |
| Q3 2018 | $2,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |